Human CD48/SLAMF2 Antibody, R&D Systems™

CD48/SLAMF2

Monoclonal

LYOPH

Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready

P09326.2

CD48

Mouse myeloma cell line NS0-derived recombinant human CD48/SLAMF2 Gln27-Ser220 Accession # P09326.2

100 μg

Primary

Detects human CD48/SLAMF2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse CD48 or recombinant human OX40 is observed.

Human

Purified

Western Blot, Flow Cytometry, CyTOF

394607

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

BCM1, BCM1 surface antigen, BCM1Leukocyte antigen MEM-102, BLAST, BLAST1, BLAST1TCT.1, B-lymphocyte activation marker BLAST-1, CD48, CD48 antigen, CD48 antigen (B-cell membrane protein), CD48 molecule, hCD48, mCD48, MEM-102, SLAMF2

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

962

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b